Co-positivity of anti-dsDNA, anti-nucleosome, and anti-smith autoantibodies as serological biomarkers for disease activity in systemic lupus erythematosus
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2090-3235
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Co-positivity of anti-dsDNA, anti-nucleosome, and anti-smith autoantibodies as serological biomarkers for disease activity in systemic lupus erythematosus ; volume:49 ; number:1 ; day:22 ; month:2 ; year:2022 ; pages:1-8 ; date:12.2022
Egyptian rheumatology & rehabilitation ; 49, Heft 1 (22.2.2022), 1-8, 12.2022
- Creator
-
Elsayed, Sahar Abdel-Rahman
Kamaly, Heba Maher
Esmail, Mohamed Ali
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s43166-021-00110-0
- URN
-
urn:nbn:de:101:1-2022042919533279204971
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Elsayed, Sahar Abdel-Rahman
- Kamaly, Heba Maher
- Esmail, Mohamed Ali
- SpringerLink (Online service)
Other Objects (12)
Influence of variable domain glycosylation on anti-neutrophil cytoplasmic autoantibodies and anti-glomerular basement membrane autoantibodies
A unique case of anti-GBM disease with concomitant anti-PLA2R positivity
Anti-neuronal autoantibodies in ischemic stroke and in anti-MAG IgM Gammopathy
Pathogenesis of anti-paranodal autoantibodies in peripheral neuropathies
Serological detection of anti-SARS-CoV-2 and anti-NY-ESO-1 specific antibodies
Expression of BAFF receptors in muscle tissue of myositis patients with anti-Jo-1 or anti-Ro52/anti-Ro60 autoantibodies
Highly quantitative serological detection of anti-cytomegalovirus (CMV) antibodies
Update and clinical management of anti-DNA auto-antibodies
Different pain phenotypes are associated with anti-Caspr2 autoantibodies
Different pain phenotypes are associated with anti-Caspr2 autoantibodies
Predictive autoimmunity using autoantibodies: screening for anti-nuclear antibodies
Anti-nuclear autoantibodies in Graves’ disease and Graves’ orbitopathy
Influence of variable domain glycosylation on anti-neutrophil cytoplasmic autoantibodies and anti-glomerular basement membrane autoantibodies
A unique case of anti-GBM disease with concomitant anti-PLA2R positivity
Anti-neuronal autoantibodies in ischemic stroke and in anti-MAG IgM Gammopathy
Pathogenesis of anti-paranodal autoantibodies in peripheral neuropathies
Serological detection of anti-SARS-CoV-2 and anti-NY-ESO-1 specific antibodies
Expression of BAFF receptors in muscle tissue of myositis patients with anti-Jo-1 or anti-Ro52/anti-Ro60 autoantibodies
Highly quantitative serological detection of anti-cytomegalovirus (CMV) antibodies
Update and clinical management of anti-DNA auto-antibodies
Different pain phenotypes are associated with anti-Caspr2 autoantibodies
Different pain phenotypes are associated with anti-Caspr2 autoantibodies
Predictive autoimmunity using autoantibodies: screening for anti-nuclear antibodies
Anti-nuclear autoantibodies in Graves’ disease and Graves’ orbitopathy
Influence of variable domain glycosylation on anti-neutrophil cytoplasmic autoantibodies and anti-glomerular basement membrane autoantibodies
A unique case of anti-GBM disease with concomitant anti-PLA2R positivity
Anti-neuronal autoantibodies in ischemic stroke and in anti-MAG IgM Gammopathy
Pathogenesis of anti-paranodal autoantibodies in peripheral neuropathies
Serological detection of anti-SARS-CoV-2 and anti-NY-ESO-1 specific antibodies
Expression of BAFF receptors in muscle tissue of myositis patients with anti-Jo-1 or anti-Ro52/anti-Ro60 autoantibodies
Highly quantitative serological detection of anti-cytomegalovirus (CMV) antibodies
Update and clinical management of anti-DNA auto-antibodies
Different pain phenotypes are associated with anti-Caspr2 autoantibodies
Different pain phenotypes are associated with anti-Caspr2 autoantibodies
Predictive autoimmunity using autoantibodies: screening for anti-nuclear antibodies